Welcome to our dedicated page for Brightspring Health Services SEC filings (Ticker: BTSGU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brightspring Health Services's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brightspring Health Services's regulatory disclosures and financial reporting.
BrightSpring Health Services, Inc. director Steven B. Miller reported a compensation-related equity grant. On May 5, 2026, he acquired 4,983 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock upon settlement. These RSUs fully vest on May 5, 2027. Following this award, Miller holds 23,106 shares of BrightSpring common stock directly.
BrightSpring Health Services, Inc. director Steven B. Miller reported a compensation-related equity grant. On May 5, 2026, he acquired 4,983 restricted stock units (RSUs), each representing a contingent right to receive one share of common stock upon settlement. These RSUs fully vest on May 5, 2027. Following this award, Miller holds 23,106 shares of BrightSpring common stock directly.
KIRTLEY OLIVIA F reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Olivia F. Kirtley received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. After this award, she directly holds 36,997 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of BrightSpring common stock upon settlement, so the grant functions as equity-based compensation rather than a cash transaction.
KIRTLEY OLIVIA F reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Olivia F. Kirtley received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. After this award, she directly holds 36,997 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of BrightSpring common stock upon settlement, so the grant functions as equity-based compensation rather than a cash transaction.
Wicks Timothy A reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Timothy A. Wicks received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. Following this award, Wicks directly holds 25,504 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of common stock upon settlement. Wicks has elected to defer settlement under BrightSpring’s Non-Employee Director Deferred Compensation Plan, so the shares will be delivered after his board service ends or on a future date he previously selected.
Wicks Timothy A reported acquisition or exercise transactions in this Form 4 filing.
BrightSpring Health Services director Timothy A. Wicks received a grant of 4,983 restricted stock units (RSUs) of common stock. The RSUs were granted on May 5, 2026 and fully vest on May 5, 2027. Following this award, Wicks directly holds 25,504 shares of BrightSpring common stock.
Each RSU represents a contingent right to receive one share of common stock upon settlement. Wicks has elected to defer settlement under BrightSpring’s Non-Employee Director Deferred Compensation Plan, so the shares will be delivered after his board service ends or on a future date he previously selected.
FMR LLC reported ownership of 21,200,804.91 shares of BrightSpring Health Services Inc. common stock, representing 10.9% of the class as disclosed on this Schedule 13G/A. The filing lists sole voting power of 21,177,426.33 shares and sole dispositive power of 21,200,804.91 shares. The cover cites CUSIP 10950A106 and an issuer address in Louisville, Kentucky. The report is signed under a Power of Attorney and references Exhibit 99 for a related agreement.
FMR LLC reported ownership of 21,200,804.91 shares of BrightSpring Health Services Inc. common stock, representing 10.9% of the class as disclosed on this Schedule 13G/A. The filing lists sole voting power of 21,177,426.33 shares and sole dispositive power of 21,200,804.91 shares. The cover cites CUSIP 10950A106 and an issuer address in Louisville, Kentucky. The report is signed under a Power of Attorney and references Exhibit 99 for a related agreement.
BrightSpring Health Services, Inc. director and officer Jon B. Rousseau reported a routine equity compensation event. In connection with the vesting of 125,012 restricted stock units, the company withheld 16,222 shares of common stock to cover tax obligations at a net settlement price equal to the $48.16 closing price on April 24, 2026. Following these tax-withholding dispositions, Rousseau directly owns 1,194,503 shares of common stock and has an additional 369,763 shares held indirectly through the Rousseau Family Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
BrightSpring Health Services, Inc. director and officer Jon B. Rousseau reported a routine equity compensation event. In connection with the vesting of 125,012 restricted stock units, the company withheld 16,222 shares of common stock to cover tax obligations at a net settlement price equal to the $48.16 closing price on April 24, 2026. Following these tax-withholding dispositions, Rousseau directly owns 1,194,503 shares of common stock and has an additional 369,763 shares held indirectly through the Rousseau Family Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
BrightSpring Health Services, Inc. is asking stockholders to vote at its virtual Annual Meeting on May 21, 2026 on three items: electing three Class II directors to serve until 2029, ratifying KPMG LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The company reports strong 2025 performance, with revenue rising to $12.9 billion and Adjusted EBITDA increasing to $618 million, driven mainly by its pharmacy solutions and provider services segments. Executive pay centers on a short‑term incentive plan tied to EBITDA, revenue growth and a quality index, with CEO base salary set at $1.4 million and a 150% target bonus opportunity. BrightSpring is no longer a Nasdaq “controlled company” after the KKR stockholder fell below majority ownership in 2025, and has formed fully independent audit and compensation committees while using a transition period to finalize a nominating and governance charter.
BrightSpring Health Services, Inc. is asking stockholders to vote at its virtual Annual Meeting on May 21, 2026 on three items: electing three Class II directors to serve until 2029, ratifying KPMG LLP as independent auditor for 2026, and approving on an advisory basis executive compensation.
The company reports strong 2025 performance, with revenue rising to $12.9 billion and Adjusted EBITDA increasing to $618 million, driven mainly by its pharmacy solutions and provider services segments. Executive pay centers on a short‑term incentive plan tied to EBITDA, revenue growth and a quality index, with CEO base salary set at $1.4 million and a 150% target bonus opportunity. BrightSpring is no longer a Nasdaq “controlled company” after the KKR stockholder fell below majority ownership in 2025, and has formed fully independent audit and compensation committees while using a transition period to finalize a nominating and governance charter.
BrightSpring Health Services President, Community Living, Robert Allen Barnes reported a routine tax-related share disposition. On March 30, 2026, 6,748 shares of common stock were withheld by the company to cover taxes due on the vesting of 15,540 restricted stock units at a net settlement price of $41.54 per share. Following this withholding, Barnes directly holds 25,549 shares of BrightSpring Health Services common stock. This was not an open-market purchase or sale but an administrative step tied to equity compensation.
BrightSpring Health Services President, Community Living, Robert Allen Barnes reported a routine tax-related share disposition. On March 30, 2026, 6,748 shares of common stock were withheld by the company to cover taxes due on the vesting of 15,540 restricted stock units at a net settlement price of $41.54 per share. Following this withholding, Barnes directly holds 25,549 shares of BrightSpring Health Services common stock. This was not an open-market purchase or sale but an administrative step tied to equity compensation.
BrightSpring Health Services completed the previously announced sale of its Community Living business, including community living services, waiver programs, and intermediate care facilities, to Sevita for aggregate cash consideration of $835 million, subject to customary working capital and other adjustments. A BrightSpring subsidiary, Res-Care, transferred the related assets, equity interests, and liabilities under a purchase agreement signed in January 2025 and amended in December 2025.
BrightSpring’s unaudited pro forma statements show the sale as if it occurred on December 31, 2025, and include an expected $425 million repayment of first lien term loan debt. The estimated after-tax gain on the sale is $31.978 million, with a modest reduction in annual interest expense. Following closing, Robert Barnes, President of ResCare Community Living, resigned and received accelerated vesting of 15,540 restricted stock units and 5,640 stock options; his departure was not due to any disagreement with the company.
BrightSpring Health Services completed the previously announced sale of its Community Living business, including community living services, waiver programs, and intermediate care facilities, to Sevita for aggregate cash consideration of $835 million, subject to customary working capital and other adjustments. A BrightSpring subsidiary, Res-Care, transferred the related assets, equity interests, and liabilities under a purchase agreement signed in January 2025 and amended in December 2025.
BrightSpring’s unaudited pro forma statements show the sale as if it occurred on December 31, 2025, and include an expected $425 million repayment of first lien term loan debt. The estimated after-tax gain on the sale is $31.978 million, with a modest reduction in annual interest expense. Following closing, Robert Barnes, President of ResCare Community Living, resigned and received accelerated vesting of 15,540 restricted stock units and 5,640 stock options; his departure was not due to any disagreement with the company.
BrightSpring Health Services director and officer Jon B. Rousseau reported multiple bona fide gifts of fully vested stock options on Common Stock. The filing shows six gift transfers covering 1,132,322 options with a conversion price of $22.29 per share, mainly to the Rousseau Family Trust, the reporting person’s spouse and The Margaret Rousseau Children Trust. These are non-cash, off-market gifts, not open-market sales or purchases. The filing notes that Rousseau disclaims beneficial ownership of indirectly held securities except to the extent of his pecuniary interest.
BrightSpring Health Services, Inc. executive Scott A. Greenwell, President of PharMerica, reported equity compensation awards on common stock and stock options. He acquired stock options for 49,073 shares at an exercise price of $0.00 per share and 20,020 shares of common stock as a grant.
According to the footnotes, the 20,020-share common stock award consists of restricted stock units that vest in three equal annual installments beginning on January 25, 2027. The 49,073 stock options also vest in three equal annual installments starting on that same date, aligning his compensation with long-term company performance.
BrightSpring Health Services, Inc. executive Scott A. Greenwell, President of PharMerica, reported equity compensation awards on common stock and stock options. He acquired stock options for 49,073 shares at an exercise price of $0.00 per share and 20,020 shares of common stock as a grant.
According to the footnotes, the 20,020-share common stock award consists of restricted stock units that vest in three equal annual installments beginning on January 25, 2027. The 49,073 stock options also vest in three equal annual installments starting on that same date, aligning his compensation with long-term company performance.